US$ 24.35
what is a glp 1 Glucagon-like peptide-1 Understanding GLP-1 and Its Role
Description
this is a personalized approach in coordination with a clinician

placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial

The two primary endpoints were the Kansas City Cardiomyopathy Questionnaire clinical summary score (KCCQ-CSS, which ranges from 0 to 100) and the Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS)

2% with dulaglutide and 3% with placebo [67]

The doses are super off compared to anything that was in research studies, like they were giving people 8,000 times the dose of what is in the patch, she says

Not the best responders
